ArticleThe oncologist2022

Phase I Study Evaluating Dose De-escalation of Sorafenib with Metformin and Atorvastatin in Hepatocellular Carcinoma (SMASH).

Vikas Ostwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.